Another study has shown that LT-171-861, a synthetic new PIM-2 inhibitor, induced DNA damage by inhibiting the HR/R pathway, activated apoptosis in MM cells, and suppressed tumor growth in MM xenograft models [74]. Here, PIM2 is linked to Miyoshi myopathy.